DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 1Accord healthcare
03 1Apotex Inc
04 1Astellas Pharma
05 1Aurobindo Pharma Limited
06 1Baxter Healthcare Corporation
07 4GE Healthcare Inc
08 1GLAND PHARMA LIMITED
09 1Hikma Pharmaceuticals
10 1Hospira, Inc.
11 1IMS srl Micronizzazioni
12 1INDIES PHARMA
13 1Meitheal Pharmaceuticals
14 1Rapidscan Pharma Solutions EU Ltd.
15 1Viatris
01 2Injectable Solution
02 1Injection fluid, resolution
03 14SOLUTION;INTRAVENOUS
04 1Solution For Injection
01 1Allowed
02 1Approved
03 1Authorized
04 14RX
05 1Blank
01 1LEXISCAN
02 13REGADENOSON
03 3Rapiscan
04 1Rapiscan ?g
01 1Norway
02 1Spain
03 1Sweden
04 1Switzerland
05 14USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2022-04-11
Application Number : 213210
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2022-04-11
Application Number : 213236
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2022-04-11
Application Number : 207604
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LEXISCAN
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2008-04-10
Application Number : 22161
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2022-10-26
Application Number : 216437
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2023-05-23
Application Number : 217455
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2024-08-05
Application Number : 215955
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Rapiscan ?g
Dosage Form : Solution For Injection
Dosage Strength : 400mcg/5ml
Packaging :
Approval Date : 28/07/2017
Application Number : 66137
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Rapiscan
Dosage Form : Injectable Solution
Dosage Strength : 400mcg/5ml
Packaging :
Approval Date : 06/09/2010
Application Number : 20090623000062
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Rapiscan
Dosage Form : Injectable Solution
Dosage Strength : 400MCG
Packaging :
Approval Date : 2013-06-28
Application Number : 110643001
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2022-07-12
Application Number : 207320
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2023-02-02
Application Number : 215827
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2022-08-31
Application Number : 214349
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2022-05-23
Application Number : 214252
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2022-04-11
Application Number : 212806
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2023-04-04
Application Number : 213856
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2024-08-22
Application Number : 218054
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Norway
Brand Name : Rapiscan
Dosage Form : Injection fluid, resolution
Dosage Strength : 400 mcg
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
